Table of Content

1 Plasma-derived Factor VIII Market Overview
1.1 Product Overview and Scope of Plasma-derived Factor VIII
1.2 Plasma-derived Factor VIII Segment by Type
1.2.1 Global Plasma-derived Factor VIII Market Value Comparison by Type (2024-2034)
1.2.2 200IU
1.2.3 250IU
1.3 Plasma-derived Factor VIII Segment by Application
1.3.1 Global Plasma-derived Factor VIII Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global Plasma-derived Factor VIII Market Size Estimates and Forecasts
1.4.1 Global Plasma-derived Factor VIII Revenue 2018-2029
1.4.2 Global Plasma-derived Factor VIII Sales 2018-2029
1.4.3 Global Plasma-derived Factor VIII Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Plasma-derived Factor VIII Market Competition by Manufacturers
2.1 Global Plasma-derived Factor VIII Sales Market Share by Manufacturers (2018-2024)
2.2 Global Plasma-derived Factor VIII Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Plasma-derived Factor VIII Average Price by Manufacturers (2018-2024)
2.4 Global Plasma-derived Factor VIII Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Plasma-derived Factor VIII, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Plasma-derived Factor VIII, Product Type & Application
2.7 Plasma-derived Factor VIII Market Competitive Situation and Trends
2.7.1 Plasma-derived Factor VIII Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Plasma-derived Factor VIII Players Market Share by Revenue
2.7.3 Global Plasma-derived Factor VIII Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Plasma-derived Factor VIII Retrospective Market Scenario by Region
3.1 Global Plasma-derived Factor VIII Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Plasma-derived Factor VIII Global Plasma-derived Factor VIII Sales by Region: 2018-2029
3.2.1 Global Plasma-derived Factor VIII Sales by Region: 2018-2024
3.2.2 Global Plasma-derived Factor VIII Sales by Region: 2024-2029
3.3 Global Plasma-derived Factor VIII Global Plasma-derived Factor VIII Revenue by Region: 2018-2029
3.3.1 Global Plasma-derived Factor VIII Revenue by Region: 2018-2024
3.3.2 Global Plasma-derived Factor VIII Revenue by Region: 2024-2029
3.4 North America Plasma-derived Factor VIII Market Facts & Figures by Country
3.4.1 North America Plasma-derived Factor VIII Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Plasma-derived Factor VIII Sales by Country (2018-2029)
3.4.3 North America Plasma-derived Factor VIII Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.4.6 Mexico
3.5 Europe Plasma-derived Factor VIII Market Facts & Figures by Country
3.5.1 Europe Plasma-derived Factor VIII Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Plasma-derived Factor VIII Sales by Country (2018-2029)
3.5.3 Europe Plasma-derived Factor VIII Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Plasma-derived Factor VIII Market Facts & Figures by Country
3.6.1 Asia Pacific Plasma-derived Factor VIII Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Plasma-derived Factor VIII Sales by Country (2018-2029)
3.6.3 Asia Pacific Plasma-derived Factor VIII Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Plasma-derived Factor VIII Market Facts & Figures by Country
3.7.1 Latin America Plasma-derived Factor VIII Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Plasma-derived Factor VIII Sales by Country (2018-2029)
3.7.3 Latin America Plasma-derived Factor VIII Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Plasma-derived Factor VIII Market Facts & Figures by Country
3.8.1 Middle East and Africa Plasma-derived Factor VIII Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Plasma-derived Factor VIII Sales by Country (2018-2029)
3.8.3 Middle East and Africa Plasma-derived Factor VIII Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Plasma-derived Factor VIII Sales by Type (2018-2029)
4.1.1 Global Plasma-derived Factor VIII Sales by Type (2018-2024)
4.1.2 Global Plasma-derived Factor VIII Sales by Type (2024-2029)
4.1.3 Global Plasma-derived Factor VIII Sales Market Share by Type (2018-2029)
4.2 Global Plasma-derived Factor VIII Revenue by Type (2018-2029)
4.2.1 Global Plasma-derived Factor VIII Revenue by Type (2018-2024)
4.2.2 Global Plasma-derived Factor VIII Revenue by Type (2024-2029)
4.2.3 Global Plasma-derived Factor VIII Revenue Market Share by Type (2018-2029)
4.3 Global Plasma-derived Factor VIII Price by Type (2018-2029)
5 Segment by Application
5.1 Global Plasma-derived Factor VIII Sales by Application (2018-2029)
5.1.1 Global Plasma-derived Factor VIII Sales by Application (2018-2024)
5.1.2 Global Plasma-derived Factor VIII Sales by Application (2024-2029)
5.1.3 Global Plasma-derived Factor VIII Sales Market Share by Application (2018-2029)
5.2 Global Plasma-derived Factor VIII Revenue by Application (2018-2029)
5.2.1 Global Plasma-derived Factor VIII Revenue by Application (2018-2024)
5.2.2 Global Plasma-derived Factor VIII Revenue by Application (2024-2029)
5.2.3 Global Plasma-derived Factor VIII Revenue Market Share by Application (2018-2029)
5.3 Global Plasma-derived Factor VIII Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Takeda
6.1.1 Takeda Corporation Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda Plasma-derived Factor VIII Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Takeda Plasma-derived Factor VIII Product Portfolio
6.1.5 Takeda Recent Developments/Updates
6.2 Octapharma
6.2.1 Octapharma Corporation Information
6.2.2 Octapharma Description and Business Overview
6.2.3 Octapharma Plasma-derived Factor VIII Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Octapharma Plasma-derived Factor VIII Product Portfolio
6.2.5 Octapharma Recent Developments/Updates
6.3 CSL
6.3.1 CSL Corporation Information
6.3.2 CSL Description and Business Overview
6.3.3 CSL Plasma-derived Factor VIII Sales, Revenue and Gross Margin (2018-2024)
6.3.4 CSL Plasma-derived Factor VIII Product Portfolio
6.3.5 CSL Recent Developments/Updates
6.4 Grifols
6.4.1 Grifols Corporation Information
6.4.2 Grifols Description and Business Overview
6.4.3 Grifols Plasma-derived Factor VIII Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Grifols Plasma-derived Factor VIII Product Portfolio
6.4.5 Grifols Recent Developments/Updates
6.5 Greencross
6.5.1 Greencross Corporation Information
6.5.2 Greencross Description and Business Overview
6.5.3 Greencross Plasma-derived Factor VIII Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Greencross Plasma-derived Factor VIII Product Portfolio
6.5.5 Greencross Recent Developments/Updates
6.6 Kedrion
6.6.1 Kedrion Corporation Information
6.6.2 Kedrion Description and Business Overview
6.6.3 Kedrion Plasma-derived Factor VIII Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Kedrion Plasma-derived Factor VIII Product Portfolio
6.6.5 Kedrion Recent Developments/Updates
6.7 BPL
6.6.1 BPL Corporation Information
6.6.2 BPL Description and Business Overview
6.6.3 BPL Plasma-derived Factor VIII Sales, Revenue and Gross Margin (2018-2024)
6.4.4 BPL Plasma-derived Factor VIII Product Portfolio
6.7.5 BPL Recent Developments/Updates
6.8 Hualan Bio
6.8.1 Hualan Bio Corporation Information
6.8.2 Hualan Bio Description and Business Overview
6.8.3 Hualan Bio Plasma-derived Factor VIII Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Hualan Bio Plasma-derived Factor VIII Product Portfolio
6.8.5 Hualan Bio Recent Developments/Updates
6.9 RAAS
6.9.1 RAAS Corporation Information
6.9.2 RAAS Description and Business Overview
6.9.3 RAAS Plasma-derived Factor VIII Sales, Revenue and Gross Margin (2018-2024)
6.9.4 RAAS Plasma-derived Factor VIII Product Portfolio
6.9.5 RAAS Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Plasma-derived Factor VIII Industry Chain Analysis
7.2 Plasma-derived Factor VIII Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Plasma-derived Factor VIII Production Mode & Process
7.4 Plasma-derived Factor VIII Sales and Marketing
7.4.1 Plasma-derived Factor VIII Sales Channels
7.4.2 Plasma-derived Factor VIII Distributors
7.5 Plasma-derived Factor VIII Customers
8 Plasma-derived Factor VIII Market Dynamics
8.1 Plasma-derived Factor VIII Industry Trends
8.2 Plasma-derived Factor VIII Market Drivers
8.3 Plasma-derived Factor VIII Market Challenges
8.4 Plasma-derived Factor VIII Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Plasma-derived Factor VIII Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Plasma-derived Factor VIII Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Plasma-derived Factor VIII Market Competitive Situation by Manufacturers in 2022
Table 4. Global Plasma-derived Factor VIII Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Plasma-derived Factor VIII Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Plasma-derived Factor VIII Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Plasma-derived Factor VIII Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Plasma-derived Factor VIII Average Price (USD/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Plasma-derived Factor VIII, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Plasma-derived Factor VIII, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Plasma-derived Factor VIII, Product Type & Application
Table 12. Global Key Manufacturers of Plasma-derived Factor VIII, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Plasma-derived Factor VIII by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma-derived Factor VIII as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Plasma-derived Factor VIII Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Plasma-derived Factor VIII Sales by Region (2018-2024) & (K Units)
Table 18. Global Plasma-derived Factor VIII Sales Market Share by Region (2018-2024)
Table 19. Global Plasma-derived Factor VIII Sales by Region (2024-2029) & (K Units)
Table 20. Global Plasma-derived Factor VIII Sales Market Share by Region (2024-2029)
Table 21. Global Plasma-derived Factor VIII Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Plasma-derived Factor VIII Revenue Market Share by Region (2018-2024)
Table 23. Global Plasma-derived Factor VIII Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Plasma-derived Factor VIII Revenue Market Share by Region (2024-2029)
Table 25. North America Plasma-derived Factor VIII Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Plasma-derived Factor VIII Sales by Country (2018-2024) & (K Units)
Table 27. North America Plasma-derived Factor VIII Sales by Country (2024-2029) & (K Units)
Table 28. North America Plasma-derived Factor VIII Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Plasma-derived Factor VIII Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Plasma-derived Factor VIII Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Plasma-derived Factor VIII Sales by Country (2018-2024) & (K Units)
Table 32. Europe Plasma-derived Factor VIII Sales by Country (2024-2029) & (K Units)
Table 33. Europe Plasma-derived Factor VIII Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Plasma-derived Factor VIII Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Plasma-derived Factor VIII Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Plasma-derived Factor VIII Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Plasma-derived Factor VIII Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Plasma-derived Factor VIII Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Plasma-derived Factor VIII Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Plasma-derived Factor VIII Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Plasma-derived Factor VIII Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Plasma-derived Factor VIII Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Plasma-derived Factor VIII Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Plasma-derived Factor VIII Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Plasma-derived Factor VIII Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Plasma-derived Factor VIII Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Plasma-derived Factor VIII Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Plasma-derived Factor VIII Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Plasma-derived Factor VIII Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Plasma-derived Factor VIII Sales (K Units) by Type (2018-2024)
Table 51. Global Plasma-derived Factor VIII Sales (K Units) by Type (2024-2029)
Table 52. Global Plasma-derived Factor VIII Sales Market Share by Type (2018-2024)
Table 53. Global Plasma-derived Factor VIII Sales Market Share by Type (2024-2029)
Table 54. Global Plasma-derived Factor VIII Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Plasma-derived Factor VIII Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Plasma-derived Factor VIII Revenue Market Share by Type (2018-2024)
Table 57. Global Plasma-derived Factor VIII Revenue Market Share by Type (2024-2029)
Table 58. Global Plasma-derived Factor VIII Price (USD/Unit) by Type (2018-2024)
Table 59. Global Plasma-derived Factor VIII Price (USD/Unit) by Type (2024-2029)
Table 60. Global Plasma-derived Factor VIII Sales (K Units) by Application (2018-2024)
Table 61. Global Plasma-derived Factor VIII Sales (K Units) by Application (2024-2029)
Table 62. Global Plasma-derived Factor VIII Sales Market Share by Application (2018-2024)
Table 63. Global Plasma-derived Factor VIII Sales Market Share by Application (2024-2029)
Table 64. Global Plasma-derived Factor VIII Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Plasma-derived Factor VIII Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Plasma-derived Factor VIII Revenue Market Share by Application (2018-2024)
Table 67. Global Plasma-derived Factor VIII Revenue Market Share by Application (2024-2029)
Table 68. Global Plasma-derived Factor VIII Price (USD/Unit) by Application (2018-2024)
Table 69. Global Plasma-derived Factor VIII Price (USD/Unit) by Application (2024-2029)
Table 70. Takeda Corporation Information
Table 71. Takeda Description and Business Overview
Table 72. Takeda Plasma-derived Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 73. Takeda Plasma-derived Factor VIII Product
Table 74. Takeda Recent Developments/Updates
Table 75. Octapharma Corporation Information
Table 76. Octapharma Description and Business Overview
Table 77. Octapharma Plasma-derived Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 78. Octapharma Plasma-derived Factor VIII Product
Table 79. Octapharma Recent Developments/Updates
Table 80. CSL Corporation Information
Table 81. CSL Description and Business Overview
Table 82. CSL Plasma-derived Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 83. CSL Plasma-derived Factor VIII Product
Table 84. CSL Recent Developments/Updates
Table 85. Grifols Corporation Information
Table 86. Grifols Description and Business Overview
Table 87. Grifols Plasma-derived Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 88. Grifols Plasma-derived Factor VIII Product
Table 89. Grifols Recent Developments/Updates
Table 90. Greencross Corporation Information
Table 91. Greencross Description and Business Overview
Table 92. Greencross Plasma-derived Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 93. Greencross Plasma-derived Factor VIII Product
Table 94. Greencross Recent Developments/Updates
Table 95. Kedrion Corporation Information
Table 96. Kedrion Description and Business Overview
Table 97. Kedrion Plasma-derived Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 98. Kedrion Plasma-derived Factor VIII Product
Table 99. Kedrion Recent Developments/Updates
Table 100. BPL Corporation Information
Table 101. BPL Description and Business Overview
Table 102. BPL Plasma-derived Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 103. BPL Plasma-derived Factor VIII Product
Table 104. BPL Recent Developments/Updates
Table 105. Hualan Bio Corporation Information
Table 106. Hualan Bio Description and Business Overview
Table 107. Hualan Bio Plasma-derived Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 108. Hualan Bio Plasma-derived Factor VIII Product
Table 109. Hualan Bio Recent Developments/Updates
Table 110. RAAS Corporation Information
Table 111. RAAS Description and Business Overview
Table 112. RAAS Plasma-derived Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 113. RAAS Plasma-derived Factor VIII Product
Table 114. RAAS Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Plasma-derived Factor VIII Distributors List
Table 118. Plasma-derived Factor VIII Customers List
Table 119. Plasma-derived Factor VIII Market Trends
Table 120. Plasma-derived Factor VIII Market Drivers
Table 121. Plasma-derived Factor VIII Market Challenges
Table 122. Plasma-derived Factor VIII Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Plasma-derived Factor VIII
Figure 2. Global Plasma-derived Factor VIII Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Plasma-derived Factor VIII Market Share by Type in 2022 & 2029
Figure 4. 200IU Product Picture
Figure 5. 250IU Product Picture
Figure 6. Global Plasma-derived Factor VIII Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Plasma-derived Factor VIII Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Pharmacy
Figure 10. Global Plasma-derived Factor VIII Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Plasma-derived Factor VIII Market Size (2018-2029) & (US$ Million)
Figure 12. Global Plasma-derived Factor VIII Sales (2018-2029) & (K Units)
Figure 13. Global Plasma-derived Factor VIII Average Price (USD/Unit) & (2018-2029)
Figure 14. Plasma-derived Factor VIII Report Years Considered
Figure 15. Plasma-derived Factor VIII Sales Share by Manufacturers in 2022
Figure 16. Global Plasma-derived Factor VIII Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Plasma-derived Factor VIII Players: Market Share by Revenue in 2022
Figure 18. Plasma-derived Factor VIII Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Plasma-derived Factor VIII Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Plasma-derived Factor VIII Sales Market Share by Country (2018-2029)
Figure 21. North America Plasma-derived Factor VIII Revenue Market Share by Country (2018-2029)
Figure 22. United States Plasma-derived Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Plasma-derived Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Mexico Plasma-derived Factor VIII Revenue Growth Rate (2018-2024) & (US$ Million)
Figure 25. Europe Plasma-derived Factor VIII Sales Market Share by Country (2018-2029)
Figure 26. Europe Plasma-derived Factor VIII Revenue Market Share by Country (2018-2029)
Figure 27. Germany Plasma-derived Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Plasma-derived Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. UK Plasma-derived Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Plasma-derived Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Plasma-derived Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Plasma-derived Factor VIII Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Plasma-derived Factor VIII Revenue Market Share by Region (2018-2029)
Figure 34. China Plasma-derived Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Plasma-derived Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Plasma-derived Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Plasma-derived Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Plasma-derived Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Plasma-derived Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Plasma-derived Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Plasma-derived Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Plasma-derived Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America Plasma-derived Factor VIII Sales Market Share by Country (2018-2029)
Figure 44. Latin America Plasma-derived Factor VIII Revenue Market Share by Country (2018-2029)
Figure 45. Mexico Plasma-derived Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil Plasma-derived Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina Plasma-derived Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Plasma-derived Factor VIII Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Plasma-derived Factor VIII Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Plasma-derived Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Plasma-derived Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE Plasma-derived Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Plasma-derived Factor VIII by Type (2018-2029)
Figure 54. Global Revenue Market Share of Plasma-derived Factor VIII by Type (2018-2029)
Figure 55. Global Plasma-derived Factor VIII Price (USD/Unit) by Type (2018-2029)
Figure 56. Global Sales Market Share of Plasma-derived Factor VIII by Application (2018-2029)
Figure 57. Global Revenue Market Share of Plasma-derived Factor VIII by Application (2018-2029)
Figure 58. Global Plasma-derived Factor VIII Price (USD/Unit) by Application (2018-2029)
Figure 59. Plasma-derived Factor VIII Value Chain
Figure 60. Plasma-derived Factor VIII Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed